Patent · US Active

Method for inactivating zika virus and for determining the completeness of inactivation

US11964008B2 · kind B2 · utility

0Cited by

1References

30Claims

0Family size

Assignee

Takeda Vaccines, Inc. · US

Inventors

Jill A. Livengood · Fort Collins, US
Holli Giebler · Cambridge, US
Hansi DEAN · Cambridge, US
Tatsuki Satou · Hikari, JP
Raman K. Rao · Palo Alto, US
Jackie Marks · Cambridge, US
Mark Lyons · Cambridge, US
Asae Shintani · Suita, JP
James Gifford · Somerville, US
Sushma Kommareddy · Cambridge, US

Key dates

Filing date	Sep 13, 2022
Grant date	Apr 23, 2024
Priority date	—
Expiry date	Nov 23, 2042

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to methods for inactivating a Zika virus which can be used in vaccines and immunogenic compositions. The present disclosure also relates to a method for determining the completeness of inactivation of an arbovirus preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.